首页> 美国政府科技报告 >PSMA-Targeted Polygadolinium Clusters: A Novel Agent for Imaging Prostate Cancer; Final rept. 30 Dec 2005-29 Dec 2007
【24h】

PSMA-Targeted Polygadolinium Clusters: A Novel Agent for Imaging Prostate Cancer; Final rept. 30 Dec 2005-29 Dec 2007

机译:psma靶向聚钆集群:一种新的前列腺癌成像剂;最终的评论。 2005年12月30日至2007年12月30日

获取原文

摘要

Controlled hydrolysis of lanthanide element or yttrium salts in the presence of amino acids yields a series of polynuclear clusters with two four twelve fourteen and fifteen lanthanide or yttrium centers bridged by hydroxides and possessing chelating amino acids. The MRI relaxivity of the gadolinium (Gd) clusters has been studied in vitro with an unprecedented large pH-dependent value of 165 mM-1 s-1 for the Gd14 cluster. We have crystallized dysprosium (Dy) analogs of the dinuclear and tetranuclear clusters for neutron diffraction analysis in order to determine the dysprosium...hydrogen (hydroxide) distance. Yttrium analogs have been prepared structurally characterized and studied by yttrium-89 NMR spectroscopy in order to determine solution structures. The first attempt at preparing a Y15 cluster gave in the presence of residual carbonate an unprecedented Y60 polyhedral cluster that suggest routes to larger Gd clusters. Europium (Eu) cluster analogs have been prepared and their reduction explored in order to exploit the Eu(ll)-Eu(lll) redox couple and develop a redox-sensitive MRl reporter for reactive oxygen species in tumors. A potentially multinuclear chelating ligand with amino acid serine moieties at each end has been prepared by multi-step organic synthesis for ditopic coordination of the Gd14 cluster.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号